We show that PD-H exhibits higher oncolytic efficiency in pancreatic cancer cells in vitro compared to both H3N-375/1TS and CVA21 and induces a growth delay in murine pancreatic KPC cell tumors in vivo. Here, PDP1 is linked to familial pancreatic carcinoma.